超越完全缓解:下咽癌与喉癌患者放疗及同步放化疗后喉功能的长期对比分析
本研究回顾性分析1999至2017年接受放疗或同步放化疗后达完全缓解的下咽癌与喉癌患者,评估功能性喉保留情况。152例患者中9例出现严重晚期吞咽困难,下咽癌和颈部淋巴结转移显著增加喉功能损害风险,功能性喉保留率在10年后持续下降。
要点
- 下咽癌与颈部淋巴结转移显著增加长期喉功能损害风险。
- 严重晚期吞咽困难平均在治疗后58.2个月出现。
- 功能性喉保留率在10年后仍持续下降,需延长监测。
核心结论
- 下咽癌和颈部淋巴结转移患者尽管肿瘤学结局成功,长期喉功能损害风险仍增加,且风险延伸至10年以上,强调需延长监测和综合支持。
研究设计与样本
- 回顾性分析1999至2017年接受放疗或同步放化疗的下咽癌和喉癌患者,共152例(下咽癌55例,喉癌97例)。
主要发现
- 152例患者中9例出现严重晚期吞咽困难,平均发生于治疗后58.2个月。
- 下咽癌和颈部淋巴结转移显著增加喉功能损害风险(分别为p < 0.001和p = 0.014)。
- 功能性喉保留率在10年后持续下降。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: This study evaluates functional larynx preservation in patients with hypopharyngeal cancer (HPC) and laryngeal cancer (LC) who achieved complete remission following radiotherapy (RT) or concurrent chemoradiation (CCRT). METHODS: HPC and LC patients treated with RT/CCRT from 1999 to 2017 were retrospectively analyzed. Severe late dysphagia and tracheostomy cases were assessed to determine laryngeal function. Long-term preservation rate of functional larynx and associated factors were evaluated. RESULTS: Of 152 patients (55 HPC, 97 LC), nine developed severe dysphagia, occurring on average 58.2 months post-treatment. HPC and cervical node metastasis significantly increased the risk of laryngeal function impairment (p < 0.001 and p = 0.014, respectively), presenting a continued decline in functional larynx preservation rate beyond 10 years. CONCLUSIONS: Patients with HPC and cervical node metastasis demonstrate an increased risk for long-term laryngeal function impairment despite successful oncologic outcomes. This risk extends beyond 10 years, underscoring the need for prolonged monitoring and comprehensive support.
引用
- Huh G, Chung EJ, Kim WS, et al. Beyond complete remission: A comparative analysis of long-term laryngeal function in patients with hypopharyngeal and laryngeal cancer following radiotherapy and concurrent chemoradiation. Head Neck. 2024. PMID: 39275863. doi:10.1002/hed.27935
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。